Mucormycosis: An emerging disease?

Clinical Microbiology and Infection

Volumn 12, Issue SUPPL. 7, 2006, Pages 7-23

  Bouza, E ^a   Munoz P ^a   Guinea, J ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Amphotericin B; Emerging; Mucorales; Mucormycosis; Zygomycetes

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CARBOHYDRATE; CASPOFUNGIN; CORTICOSTEROID; DEFEROXAMINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IRON CHELATING AGENT; ITRACONAZOLE; MICAFUNGIN; OXYGEN; POSACONAZOLE; RAVUCONAZOLE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ASPERGILLOSIS; AUTOPSY; BANDAGE; BRAIN; CANDIDIASIS; CATHETER; DEBRIDEMENT; DEVICE; DIABETES MELLITUS; DISEASE PREDISPOSITION; DRUG CHOICE; DRUG MEGADOSE; DRUG TREATMENT FAILURE; DRUG USE; FUNGAL COLONIZATION; FUNGAL CONTAMINATION; FUNGAL MORPHOLOGY; FUNGUS CULTURE; FUNGUS GROWTH; FUNGUS ISOLATION; FUNGUS SPORE; GASTROINTESTINAL TRACT; HISTOPATHOLOGY; HUMAN; HYPERBARIC OXYGEN; IATROGENIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; INCIDENCE; INGESTION; INOCULATION; KETOACIDOSIS; LOW DRUG DOSE; LUNG; MORTALITY; MUCORALES; MUCORMYCOSIS; MUCOSA; MYCOSIS; NONHUMAN; PARANASAL SINUS; PERMEABILITY BARRIER; PRIORITY JOURNAL; REVIEW; RHIZOPUS ORYZAE; RISK FACTOR; SKIN; SYMPTOM; TEMPERATURE; ZYGOMYCETES;

FUNGI; MUCORALES; RHIZOPUS ORYZAE; ZYGOMYCETES;

EID: 33751041543     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01604.x     Document Type: Review

References (351)

1. Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: A review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect 2004; 10(suppl 1): 31-47.
2. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000; 13: 236-301.
3. Cohen-Abbo A, Bozeman PM, Patrick CC. Cunninghamella infections. review and report of two cases of Cunninghamella pneumonia in immunocompromised children. Clin Infect Dis 1993; 17: 173-177.
4. Kontoyianis DP, Vartivarian S, Anaissie EJ, Samonis G, Bodey GP, Rinaldi M. Infections due to Cunninghamella bertholletiae in patients with cancer: Report of three cases and review. Clin Infect Dis 1994; 18: 925-928.
5. Kwon-Chung KJ, Young RC, Orlando M. Pulmonary mucormycosis caused by Cunninghamella elegans in a patient with chronic myelogenous leukemia. Am J Clin Pathol 1975; 64: 544-548.
6. Ventura GJ, Kantarjian HM, Anaissie E, Hopfer RL, Fainstein V. Pneumonia with Cunninghamella species in patients with hematologic malignancies. A case report and review of the literature. Cancer 1986; 58: 1534-1536.
7. Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: Results of population-based laboratory active surveillance. Clin Infect Dis 1998; 27: 1138-1147.
8. Hotchi M, Okada M, Nasu T. Present state of fungal infections in autopsy cases in Japan. Am J Clin Pathol 1980; 74: 410-416.
9. Tietz HJ, Brehmer D, Janisch W, Martin H. Incidence of endomycoses in the autopsy material of the Berlin Charite Hospital. Mycoses 1998; 41(suppl 2): 81-85.
10. Yamazaki T, Kume H, Murase S, Yamashita E, Arisawa M. Epidemiology of visceral mycoses: Analysis of data in annual of the pathological autopsy cases in Japan. J Clin Microbiol 1999; 37: 1732-1738.
11. Maertens J, Demuynck H, Verbeken EK et al. Mucormycosis in allogeneic bone marrow transplant recipients: Report of five cases and review of the role of iron overload in the pathogenesis. Bone Marrow Transplant 1999; 24: 307-312.
12. Marty FM, Cosimi LA, Baden LR. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med 2004; 350: 950-952.
13. Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KV. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis 2000; 30: 851-856.
14. Nussbaum ES, Hall WA. Rhinocerebral mucormycosis: Changing patterns of disease. Surg Neurol 1994; 41: 152-156.
15. Rickerts V, Bohme A, Just-Nubling G. Risk factor for invasive zygomycosis in patients with hematologic malignancies. Mycoses 2002; 45(suppl 1): 27-30.
16. Kauffman CA. Zygomycosis: Reemergence of an old pathogen. Clin Infect Dis 2004; 39: 588-590.
17. Gartenberg G, Bottone EJ, Keusch GT, Weitzman I. Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue: epidemiology, mycology and treatment. N Engl J Med 1978; 299: 1115-1118.
18. Petrikkos G, Skiada A, Sambatakou H et al. Mucormycosis: Ten-year experience at a tertiary-care center in Greece. Eur J Clin Microbiol Infect Dis 2003; 22: 753-756.
19. Baraia J, Munoz P, Bernaldo de Quiros JC, Bouza E. Cutaneous mucormycosis in a heart transplant patient associated with a peripheral catheter. Eur J Clin Microbiol Infect Dis 1995; 14: 813-815.
20. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 909-917.
21. Siwek GT, Dodgson KJ, de Magalhaes-Silverman M et al. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis 2004; 39: 584-587.
22. Vigouroux S, Morin O, Moreau P et al. Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required. Clin Infect Dis 2005; 40: E35-e37.
23. Chamilos G, Marom EM, Lewis RE, Lionakis MS, Kontoyiannis DP. Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis 2005; 41: 60-66.
24. Ide L, Buysschaert I, Demuynck H et al. Zygomycosis in neutropenic patients with past Aspergillus infection: A role for posaconazole? Clin Microbiol Infect 2004; 10: 862-863.
25. Imhof A, Balajee SA, Fredricks DN, Englund JA, Marr KA. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis 2004; 39: 743-746.
26. Jacobs P, Wood L, Du Toit A, Esterhuizen K. Eradication of invasive mucormycosis-effectiveness of the Echinocandin FK463. Hematology 2003; 8: 119-123.
27. Wingard JR. The changing face of invasive fungal infections in hematopoietic cell transplant recipients. Curr Opin Oncol 2005; 17: 89-92.
28. Ritz N, Ammann RA, Aebischer CC et al. Failure of voriconazole to cure disseminated zygomycosis in an immunocompromised child. Eur J Pediatr 2005; 164: 231-235.
29. Oren I. Breakthrough zygomycosis during empirical voriconazole therapy in febrile patients with neutropenia. Clin Infect Dis 2005; 40: 770-771.
30. Lionakis MS, Kontoyiannis DP. Sinus zygomycosis in a patient receiving voriconazole prophylaxis. Br J Haematol 2005; 129: 2.
31. Kontoyiannis DP, Lionakis MS, Lewis RE et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: A case-control observational study of 27 recent cases. J Infect Dis 2005; 191: 1350-1359.
32. Waldorf AR. Pulmonary defense mechanisms against opportunistic fungal pathogens. Immunol Ser 1989; 47: 243-271.
33. Waldorf AR, Ruderman N, Diamond RD. Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus. J Clin Invest 1984; 74: 150-160.
34. Diamond RD, Haudenschild CC, Erickson NF 3rd. Monocyte-mediated damage to Rhizopus oryzae hyphae in vitro. Infect Immun 1982; 38: 292-297.
35. Chinn RY, Diamond RD. Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum: Relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis. Infect Immun 1982; 38: 1123-1129.
36. Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: Pathophysiology, presentation, and management. Clin Microbiol Rev 2005; 18: 556-569.
37. Boelaert JR, de Locht M, Van Cutsem J et al. Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. J Clin Invest 1993; 91: 1979-1986.
38. Abe F, Inaba H, Katoh T, Hotchi M. Effects of iron and desferrioxamine on Rhizopus infection. Mycopathologia 1990; 110: 87-91.
39. Amin SB, Ryan RM, Metlay LA, Watson WJ. Absidia corymbifera infections in neonates. Clin Infect Dis 1998; 26: 990-992.
40. Van Cutsem J, Boelaert JR. Effects of deferoxamine, feroxamine and iron on experimental mucormycosis (zygomycosis). Kidney Int 1989; 36: 1061-1068.
41. Artis WM, Fountain JA, Delcher HK, Jones HE. A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: Transferrin and iron availability. Diabetes 1982; 31: 1109-1114.
42. Ibrahim AS, Spellberg B, Avanessian V, Fu Y, Edwards JE Jr. Rhizopus oryzae adheres to, is phagocytosed by, and damages endothelial cells in vitro. Infect Immun 2005; 73: 778-783.
43. Ingram CW, Sennesh J, Cooper JN, Perfect JR. Disseminated zygomycosis: report of four cases and review. Rev Infect Dis 1989; 11: 741-754.
44. Herbrecht R, Letscher-Bru V, Bowden RA et al. Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion. Eur J Clin Microbiol Infect Dis 2001; 20: 460-466.
45. Baddley JW, Stroud TP, Salzman D, Pappas PG. Invasive mold infections in allogeneic bone marrow transplant recipients. Clin Infect Dis 2001; 32: 1319-1324.
46. Morrison VA, McGlave PB. Mucormycosis in the BMT population. Bone Marrow Transplant 1993; 11: 383-388.
47. Nosari A, Oreste P, Montillo M et al. Mucormycosis in hematologic malignancies: An emerging fungal infection. Haematologica 2000; 85: 1068-1071.
48. Jimenez C, Lumbreras C, Aguado JM et al. Successful treatment of mucor infection after liver or pancreas-kidney transplantation. Transplantation 2002; 73: 476-480.
49. Nampoory MR, Khan ZU, Johny KV et al. Invasive fungal infections in renal transplant recipients. J Infect 1996; 33: 95-101.
50. Morduchowicz G, Shmueli D, Shapira Z et al. Rhinocerebral mucormycosis in renal transplant recipients: Report of three cases and review of the literature. Rev Infect Dis 1986; 8: 441-446.
51. Sehgal A, Raghavendran M, Kumar D, Srivastava A, Dubey D, Kumar A. Rhinocerebral mucormycosis causing basilar artery aneurysm with concomitant fungal colonic perforation in renal allograft recipient: A case report. Transplantation 2004; 78: 949-950.
52. Quinio D, Karam A, Leroy JP et al. Zygomycosis caused by Cunninghamella bertholletiae in a kidney transplant recipient. Med Mycol 2004; 42: 177-180.
53. Mattner F, Weissbrodt H, Strueber M. Two case reports: Fatal Absidia corymbifera pulmonary tract infection in the first postoperative phase of a lung transplant patient receiving voriconazole prophylaxis, and transient bronchial Absidia corymbifera colonization in a lung transplant patient. Scand J Infect Dis 2004; 36: 312-314.
54. Kerbaul F, Guidon C, Collart F et al. Abdominal wall mucormycosis after heart transplantation. J Cardiothorac Vasc Anesth 2004; 18: 822-823.
55. Tobon AM, Arango M, Fernandez D, Restrepo A. Mucormycosis (zygomycosis) in a heart-kidney transplant recipient: Recovery after posaconazole therapy. Clin Infect Dis 2003; 36: 1488-1491.
56. Minz M, Sharma A, Kashyap R et al. Isolated renal allograft arterial mucormycosis: An extremely rare complication. Nephrol Dial Transplant 2003; 18: 1034-1035.
57. Ladurner R, Brandacher G, Steurer W et al. Lessons to be learned from a complicated case of rhino-cerebral mucormycosis in a renal allograft recipient. Transpl Int 2003; 16: 885-889.
58. Zhang R, Zhang JW, Szerlip HM. Endocarditis and hemorrhagic stroke caused by Cunninghamella bertholletiae infection after kidney transplantation. Am J Kidney Dis 2002; 40: 842-846.
59. Vera A, Hubscher SG, McMaster P, Buckels JA. Invasive gastrointestinal zygomycosis in a liver transplant recipient: Case report. Transplantation 2002; 73: 145-147.
60. Warnock DW. Fungal complications of transplantation: Diagnosis, treatment and prevention. J Antimicrob Chemother 1995; 36(suppl B): 73-90.
61. Bertocchi M, Thevenet F, Bastien O et al. Fungal infections in lung transplant recipients. Transplant Proc 1995; 27: 1695.
62. Carbone KM, Pennington LR, Gimenez LF, Burrow CR, Watson AJ. Mucormycosis in renal transplant patients - a report of two cases and review of the literature. Q J Med 1985; 57: 825-831.
63. Haim S, Better OS, Lichtig C, Erlik D, Barzilai A. Rhinocerebral mucormycosis following kidney transplantation. Isr J Med Sci 1970; 6: 646-649.
64. Kubota N, Miyazawa K, Shoji N et al. A massive intraventricular thrombosis by disseminated mucormycosis in a patient with myelodysplastic syndrome during deferoxamine therapy. Haematologica 2003; 88: EIM13.
65. Venkattaramanabalaji GV, Foster D, Greene JN et al. Mucormycosis associated with deferoxamine therapy after allogeneic bone marrow transplantation. Cancer Control 1997; 4: 168-171.
66. Prokopowicz GP, Bradley SF, Kauffman CA. Indolent zygomycosis associated with deferoxamine chelation therapy. Mycoses 1994; 37: 427-431.
67. Boelaert JR, Van Cutsem J, de Locht M, Schneider YJ, Crichton RR. Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect. Kidney Int 1994; 45: 667-671.
68. Boelaert JR, de Locht M, Schneider YJ. The effect of deferoxamine on different zygomycetes. J Infect Dis 1994; 169: 231-232.
69. Vlasveld LT, Sweder van Asbeck B. Treatment with deferoxamine: A real risk factor for mucormycosis? Nephron 1991; 57: 487-488.
70. Slade MP, McNab AA. Fatal mucormycosis therapy associated with deferoxamine. Am J Ophthalmol 1991; 112: 594-595.
71. Ponz E, Campistol JM, Ribalta T et al. Mucormicosis diseminada en una paciente hemodializada en tratamiento con deferroxiamina. Rev Clin Esp 1991; 188: 85-87.
72. Boelaert JR, Fenves AZ, Coburn JW. Deferoxamine therapy and mucormycosis in dialysis patients: Report of an international registry. Am J Kidney Dis 1991; 18: 660-667.
73. Vandevelde L, Bondewel C, Dubois M, De Vuyst M. Mucorales and deferoxamine: From saprophytic to pathogenic state. Acta Otorhinolaryngol Belg 1990; 44: 429-433.
74. Sane A, Manzi S, Perfect J, Herzberg AJ, Moore JO. Deferoxamine treatment as a risk factor for zygomycete infection. J Infect Dis 1989; 159: 151-152.
75. Eiser AR, Slifkin RF, Neff MS. Intestinal mucormycosis in hemodialysis patients following deferoxamine. Am J Kidney Dis 1987; 10: 71-73.
76. Goodill JJ, Abuelo JG. Mucormycosis-a new risk of deferoxamine therapy in dialysis patients with aluminum or iron overload? N Engl J Med 1987; 317: 54.
77. Veis JH, Contiguglia R, Klein M, Mishell J, Alfrey AC, Shapiro JI. Mucormycosis in deferoxamine-treated patients on dialysis. Ann Intern Med 1987; 107: 258.
78. Windus DW, Stokes TJ, Julian BA, Fenves AZ. Fatal Rhizopus infections in hemodialysis patients receiving deferoxamine. Ann Intern Med 1987; 107: 678-680.
79. Rex JH, Ginsberg AM, Fries LF, Pass HI, Kwon-Chung KJ. Cunninghamella bertholletiae infection associated with deferoxamine therapy. Rev Infect Dis 1988; 10: 1187-1194.
80. McNab AA, McKelvie P. Iron overload is a risk factor for zygomycosis. Arch Ophthalmol 1997; 115: 919-921.
81. MacDonald ML, Weiss PJ, Deloach-Banta LJ, Comer SW. Primary cutaneous mucormycosis with a Mucor species: Is iron overload a factor? Cutis 1994; 54: 275-278.
82. Sugar AM. Mucormycosis. Clin Infect Dis 1992; 14(suppl 1): S126-S129.
83. Garcia-Covarrubias L, Bartlett R, Barratt DM, Wassermann RJ. Rhino-orbitocerebral mucormycosis attributable to Apophysomyces elegans in an immunocompetent individual: Case report and review of the literature. J Trauma 2001; 50: 353-357.
84. Mastroianni A. Paranasal sinus mucormycosis in an immunocompetent host: efficacy and safety of combination therapy with liposomal amphotericin B and adjuvant rHuGM-CSF. Infez Med 2004; 12: 278-283.
85. Scharf JL, Soliman AM. Chronic rhizopus invasive fungal rhinosinusitis in an immunocompetent host. Laryngoscope 2004; 114: 1533-1535.
86. Solano T, Atkins B, Tambosis E, Mann S, Gottlieb T. Disseminated mucormycosis due to Saksenaea vasiformis in an immunocompetent adult. Clin Infect Dis 2000; 30: 942-943.
87. Fairley C, Sullivan TJ, Bartley P, Allworth T, Lewandowski R. Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient. Ophthalmology 2000; 107: 555-558.
88. Carr EJ, Scott P, Gradon JD. Fatal gastrointestinal mucormycosis that invaded the postoperative abdominal wall wound in an immunocompetent host. Clin Infect Dis 1999; 29: 956-957.
89. Burrell SR, Ostlie DJ, Saubolle M, Dimler M, Barbour SD. Apophysomyces elegans infection associated with cactus spine injury in an immunocompetent pediatric patient. Pediatr Infect Dis J 1998; 17: 663-664.
90. Al-Asiri RH, Van Dijken PJ, Mahmood MA, Al-Shahed MS, Rossi ML, Osoba AO. Isolated hepatic mucormycosis in an immunocompetent child. Am J Gastroenterol 1996; 91: 606-607.
91. Roden MM, Zaoutis TE, Buchanan WL et al. Epidemiology and outcome of zygomycosis: A review of 929 reported cases. Clin Infect Dis 2005; 41: 634-653.
92. Zaizen Y, Ohtsu T. Successful treatment of pulmonary mucormycosis, a rare pulmonary fungal infection, in a patient with diabetes mellitus. J Thorac Cardiovasc Surg 2002; 124: 838-840.
93. Tryfon S, Stanopoulos I, Kakavelas E, Nikolaidou A, Kioumis I. Rhinocerebral mucormycosis in a patient with latent diabetes mellitus: A case report. J Oral Maxillofac Surg 2002; 60: 328-330.
94. Moye J, Rosenbloom AL, Silverstein J. Clinical predictors of mucormycosis in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2002; 15: 1001-1004.
95. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med 1999; 341: 1906-1912.
96. Zimhony O, Israeli E, Malnick SD, Pansky A, Cohen P, Geltner D. Zygomycotic gangrenous cellulitis in a patient with non-insulin dependent diabetes mellitus. West J Med 1998; 168: 192-194.
97. Rocha G, Garza G, Font RL. Orbital pathology associated with diabetes mellitus. Int Ophthalmol Clin 1998; 38: 169-179.
98. Goswami R, Tandon N, Thulkar S, Kochupillai N. Diabetes mellitus, fever, proptosis, and rapid loss of vision. Postgrad Med J 1996; 72: 633-635.
99. Tierney MR, Baker AS. Infections of the head and neck in diabetes mellitus. Infect Dis Clin North Am 1995; 9: 195-216.
100. Smitherman KO, Peacock JE Jr. Infectious emergencies in patients with diabetes mellitus. Med Clin North Am 1995; 79: 53-77.
101. Ryan-Poirier K, Eiseman RM, Beaty JH, Hunt PG, Burghen GA, Leggiadro RJ. Post-traumatic cutaneous mucormycosis in diabetes mellitus. Short-term antifungal therapy. Clin Pediatr (Phil) 1988; 27: 609-612.
102. Anderson NE, Ali MR, Simpson IJ. Rhinocerebral mucormycosis complicating poorly controlled diabetes mellitus: Case report. N Z Med J 1983; 96: 521-522.
103. Rashid M, Bari A, Majeed S, Tariq KM, Haq I, Niwaz A. Mucormycosis: A devastating fungal infection in diabetics. J Coll Physicians Surg Pak 2005; 15: 43-45.
104. Chadli-Chaieb M, Bchir A, Fathallah-Mili A et al. Mucormycosis in the diabetic patient. Presse Med 2005; 34: 218-222.
105. Shi BY, Lan L, Guo H, Tan YF. Concomitant diabetic ketoacidosis and rhinocerebral mucormycosis: Report of a case. Chin Med J (Engl) 2004; 117: 1113-1115.
106. Waldorf AR, Levitz SM, Diamond RD. In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J Infect Dis 1984; 150: 752-760.
107. Lionakis MS, Kontoyiannis DP. The significance of isolation of saprophytic molds from the lower respiratory tract in patients with cancer. Cancer 2004; 100: 165-172.
108. Van den Saffele JK, Boelaert JR. Zygomycosis in HIV-positive patients: A review of the literature. Mycoses 1996; 39: 77-84.
109. Keogh CF, Brown JA, Phillips P, Cooperberg PL. Renal mucormycosis in an AIDS patient: Imaging features and pathologic correlation. AJR Am J Roentgenol 2003; 180: 1278-1280.
110. Fujii T, Takata N, Katsutani S, Kimura A. Disseminated mucormycosis in an acquired immunodeficiency syndrome (AIDS) patient. Intern Med 2003; 42: 129-130.
111. Virally ML, Riveline JP, Virally J et al. Pulmonary mucormycosis in a diabetic patient with HIV. Diabetes Care 2002; 25: 2105.
112. Hejny C, Kerrison JB, Newman NJ, Stone CM. Rhino-orbital mucormycosis in a patient with acquired immunodeficiency syndrome (AIDS) and neutropenia. Am J Ophthalmol 2001; 132: 111-112.
113. Moraru RA, Grossman ME. Palatal necrosis in an AIDS patient: A case of mucormycosis. Cutis 2000; 66: 15-18.
114. Guardia JA, Bourgoignie J, Diego J. Renal mucormycosis in the HIV patient. Am J Kidney Dis 2000; 35: E24.
115. Weinberg JM, Baxt RD, Egan CL, Rook AH, Atillasoy ES, Ragsdale BD. Mucormycosis in a patient with acquired immunodeficiency syndrome. Arch Dermatol 1997; 133: 249-251.
116. Carvalhal GF, Machado MG, Pompeo A, Saldanha L, Sabbaga E, Arap S. Mucormycosis presenting as a renal mass in a patient with the human immunodeficiency virus. J Urol 1997; 158: 2230-2231.
117. Abril V, Ortega E, Segarra P, Pedro F, Sabater V, Herrera A. Rhinocerebral mucormycosis in a patient with AIDS: A complication of diabetic ketoacidosis following pentamidine therapy. Clin Infect Dis 1996; 23: 845-846.
118. Bouza E. Nuevos aspectos sobre las infecciones causadas por Aspergillus y Mucor y otros hongos filamentosos en pacientes inmunodeprimidos. Rev Clin Esp 1995; 195(suppl 3): 15-25.
119. Sanchez MR, Ponge-Wilson I, Moy JA, Rosenthal S. Zygomycosis and HIV infection. J Am Acad Dermatol 1994; 30: 904-908.
120. Torres-Rodriguez JM, Lowinger M, Corominas JM, Madrenys N, Saballs P. Renal infection due to Absidia corymbifera in an AIDS patient. Mycoses 1993; 36: 255-258.
121. Brullet E, Andreu X, Elias J, Roig J, Cervantes M. Gastric mucormycosis in a patient with acquired immunodeficiency syndrome. Gastrointest Endosc 1993; 39: 106-107.
122. Fong KM, Seneviratne EM, McCormack JG. Mucor cerebral abscess associated with intravenous drug abuse. Aust N Z J Med 1990; 20: 74-77.
123. Kasantikul V, Shuangshoti S, Taecholarn C. Primary phycomycosis of the brain in heroin addicts. Surg Neurol 1987; 28: 468-472.
124. Woods KF, Hanna BJ. Brain stem mucormycosis in a narcotic addict with eventual recovery. Am J Med 1986; 80: 126-128.
125. Micozzi MS, Wetli CV. Intravenous amphetamine abuse, primary cerebral mucormycosis, and acquired immunodeficiency. J Forensic Sci 1985; 30: 504-510.
126. Hay RJ. Mucormycosis: An infectious complication of traumatic injury. Lancet 2005; 365: 830-831.
127. Lucas JB, Salyer RD, Watson DW. Gangrenous primary cutaneous mucormycosis of the scalp in an iatrogenically immunosuppressed trauma patient. Otolaryngol Head Neck Surg 2003; 128: 912-914.
128. Song WK, Park HJ, Cinn YW, Rheem I, Pai H, Shin JH. Primary cutaneous mucormycosis in a trauma patient. J Dermatol 1999; 26: 825-828.
129. Seguin P, Musellec H, Le Gall F, Chevrier S, Le Bouquin V, Malledant Y. Post-traumatic course complicated by cutaneous infection with Absidia corymbifera. Eur J Clin Microbiol Infect Dis 1999; 18: 737-739.
130. Scalise A, Barchiesi F, Viviani MA, Arzeni D, Bertani A, Scalise G. Infection due to Absidia corymbifera in a patient with a massive crush trauma of the foot. J Infect 1999; 38: 191-192.
131. Torcal J, Salinas JC, Lozano R, Mena MV, Luque MP, de Miguel R. Secondary vulvar and pulmonary mucormycosis in a trauma patient. Infection 1998; 26: 192-193.
132. Fortun J, Cobo J, Canal J, Martinez-San Millan J. Post-traumatic cranial mucormycosis in an immunocompetent patient. J Oral Maxillofac Surg 1995; 53: 1099-1102.
133. Taams M, Bade PG, Thomson SR. Post-traumatic abdominal mucormycosis. Injury 1992; 23: 390-392.
134. Okhuysen PC, Rex JH, Kapusta M, Fife C. Successful treatment of extensive posttraumatic soft-tissue and renal infections due to Apophysomyces elegans. Clin Infect Dis 1994; 19: 329-331.
135. Cocanour CS, Miller-Crotchett P, Reed RL 2nd, Johnson PC, Fischer RP. Mucormycosis in trauma patients. J Trauma 1992; 32: 12-15.
136. Huffnagle KE, Southern PM Jr, Byrd LT, Gander RM. Apophysomyces elegans as an agent of zygomycosis in a patient following trauma. J Med Vet Mycol 1992; 30: 83-86.
137. Gordon G, Indeck M, Bross J, Kapoor DA, Brotman S. Injury from silage wagon accident complicated by mucormycosis. J Trauma 1988; 28: 866-867.
138. Johnson PC, Satterwhite TK, Monheit JE, Parks D. Primary cutaneous mucormycosis in trauma patients. J Trauma 1987; 27: 437-441.
139. Potvliege C, Crokaert F, Hooghe L, De Mey A. Post-traumatic gangrene and systemic mucormycosis. J Infect 1983; 6: 277-278.
140. Webster RG Jr, Abbott RL, Spencer WH. Persistent infection of a posttraumatic phycomycotic infection. Arch Ophthalmol 1980; 98: 383-384.
141. Ignelzi RJ, VanderArk GD. Cerebral mucormycosis following open head trauma. Case report. J Neurosurg 1975; 42: 593-596.
142. Schwartz LK, Loignon LM, Webster RG Jr. Posttraumatic phycomycosis of the anterior segment. Arch Ophthalmol 1978; 96: 860-863.
143. Grigorian A, Rajaraman V, Hunt CD. Traumatic intracranial aneurysms complicating anterior skull base surgery. J Craniomaxillofac Trauma 1998; 4: 10-14.
144. Marshall DH, Brownstein S, Jackson WB, Mintsioulis G, Gilberg SM, al-Zeerah BF. Post-traumatic corneal mucormycosis caused by Absidia corymbifera. Ophthalmology 1997; 104: 1107-1111.
145. Narain S, Mitra M, Barton RC, Evans EG, Hutchinson C. Post-traumatic fungal keratitis caused by Absidia corymbifera, with successful medical treatment. Eye 2001; 15: 352-353.
146. Carter JE, Ulusarac O. Widespread cutaneous involvement by invasive Apophysomyces elegans in a gravid patient following trauma. Cutis 2003; 72: 227-228.
147. Andresen D, Donaldson A, Choo L et al. Multifocal cutaneous mucormycosis complicating polymicrobial wound infections in a tsunami survivor from Sri Lanka. Lancet 2005; 365: 876-878.
148. Chakrabarti A, Das A, Sharma A et al. Ten years' experience in zygomycosis at a tertiary care centre in India. J Infect 2005; 42: 261-266.
149. Khor BS, Lee MH, Leu HS, Liu JW. Rhinocerebral mucormycosis in Taiwan. J Microbiol Immunol Infect 2003; 36: 266-269.
150. McNulty JS. Rhinocerebral mucormycosis: Predisposing factors. Laryngoscope 1982; 92: 1140-1143.
151. Nithyanandam S, Jacob MS, Battu RR, Thomas RK, Correa MA, D'Souza O. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. Ind J Ophthalmol 2003; 51: 231-236.
152. Peterson KL, Wang M, Canalis RF, Abemayor E. Rhinocerebral mucormycosis: evolution of the disease and treatment options. Laryngoscope 1997; 107: 855-862.
153. Barron MA, Lay M, Madinger NE. Surgery and treatment with high-dose liposomal amphotericin B for eradication of craniofacial zygomycosis in a patient with Hodgkin's disease who had undergone allogeneic hematopoietic stem cell transplantation. J Clin Microbiol 2005; 43: 2012-2014.
154. McAdams HP, Rosado de Christenson M, Strollo DC, Patz EF Jr. Pulmonary mucormycosis: Radiologic findings in 32 cases. AJR Am J Roentgenol 1997; 168: 1541-1548.
155. Tedder M, Spratt JA, Anstadt MP, Hegde SS, Tedder SD, Lowe JE. Pulmonary mucormycosis: Results of medical and surgical therapy. Ann Thorac Surg 1994; 57: 1044-1150.
156. Adam RD, Hunter G, DiTomasso J, Comerci G Jr. Mucormycosis: Emerging prominence of cutaneous infections. Clin Infect Dis 1994; 19: 67-76.
157. Alsuwaida K. Primary cutaneous mucormycosis complicating the use of adhesive tape to secure the endotracheal tube. Can J Anaesth 2002; 49: 880-882.
158. Kerr OA, Bong C, Wallis C, Tidman MJ. Primary cutaneous mucormycosis masquerading as pyoderma gangrenosum. Br J Dermatol 2004; 150: 1212-1213.
159. Perez-Uribe A, Molina de Soschin D, Arenas R, Reyes M. Mucormicosis cutánea primaria en un paciente infectado con el virus de la inmunodeficiencia humana. Rev Iberoam Micol 2005; 22: 118-121.
160. Stamm B. Mucormycosis of the stomach in a patient with multiple trauma. Histopathology 2005; 47: 222-223.
161. Teggi A, Fedele A, Bagnato R, Traditi F, Lanzalone CM, De Rosa F. A case of disseminated mucormycosis. Recenti Prog Med 1989; 80: 308-313.
162. Chen L, Xiao Y, Wang X. Successful treatment of mucormycosis in the pulmonary artery after cardiac surgery. J Card Surg 2005; 20: 186-188.
163. Pillsbury HC, Fischer ND. Rhinocerebral mucormycosis. Arch Otolaryngol 1977; 103: 600-604.
164. Thajeb P, Thajeb T, Dai D. Fatal strokes in patients with rhino-orbito-cerebral mucormycosis and associated vasculopathy. Scand J Infect Dis 2004; 36: 643-648.
165. Bhansali A, Bhadada S, Sharma A et al. Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes. Postgrad Med J 2004; 80: 670-674.
166. Severo LC, Oliveira FD, Dreher R, Teixeira PZ, Porto ND, Londero AT. Zygomycosis: A report of eleven cases and a review of the Brazilian literature. Rev Iberoam Micol 2002; 19: 52-56.
167. Dokmetas HS, Canbay E, Yilmaz S et al. Diabetic ketoacidosis and rhino-orbital mucormycosis. Diabetes Res Clin Pract 2002; 57: 139-142.
168. Wehl G, Hoegler W, Kropshofer G, Meister B, Fink FM, Heitger A. Rhinocerebral mucormycosis in a boy with recurrent acute lymphoblastic leukemia: Long-term survival with systemic antifungal treatment. J Pediatr Hematol Oncol 2002; 24: 492-494.
169. Ryan M, Yeo S, Maguire A et al. Rhinocerebral zygomycosis in childhood acute lymphoblastic leukaemia. Eur J Pediatr 2001; 160: 235-238.
170. Lerchenmuller C, Goner M, Buchner T, Berdel WE. Rhinocerebral zygomycosis in a patient with acute lymphoblastic leukemia. Ann Oncol 2001; 12: 415-419.
171. Cagatay AA, Oncu SS, Calangu SS, Yildirmak TT, Ozsut HH, Eraksoy HH. Rhinocerebral mucormycosis treated with 32 gram liposomal amphotericin B and incomplete surgery: A case report. BMC Infect Dis 2001; 1: 22.
172. Parkyn T, McNinch AW, Riordan T, Mott M. Zygomycosis in relapsed acute leukaemia. J Infect 2000; 41: 265-268.
173. Penalver FJ, Romero R, Fores R et al. Rhinocerebral mucormycosis following donor leukocyte infusion: Successful treatment with liposomal amphotericin B and surgical debridement. Bone Marrow Transplant 1998; 22: 817-818.
174. Apaydin S, Ataman R, Cansiz H et al. Rhinocerebral mucormycosis in a kidney transplant recipient. Nephron 1998; 79: 117-118.
175. Martinez EJ, Cancio MR, Sinnott JT, Vincent AL, Brantley SG. Nonfatal gastric mucormycosis in a renal transplant recipient. South Med J 1997; 90: 341-344.
176. Piliero PJ, Deresiewicz RL. Pulmonary zygomycosis after allogeneic bone marrow transplantation. South Med J 1995; 88: 1149-1152.
177. Singh N, Gayowski T, Singh J, Yu VL. Invasive gastrointestinal zygomycosis in a liver transplant recipient: Case report and review of zygomycosis in solid-organ transplant recipients. Clin Infect Dis 1995; 20: 617-620.
178. Budreau JP, Straatman D, Mogridge C, Dutton S, Fish JC. Rhinocerebral mucormycosis in a cyclosporine-treated renal transplant patient. Clin Transpl 1989; 305.
179. Abedi E, Sismanis A, Choi K, Pastore P. Twenty-five years' experience treating cerebro-rhino-orbital mucormycosis. Laryngoscope 1984; 94: 1060-1062.
180. Gleissner B, Schilling A, Anagnostopolous I, Siehl I, Thiel E. Improved outcome of zygomycosis in patients with hematological diseases? Leuk Lymphoma 2004; 45: 1351-1360.
181. Wens R, Devriendt J, Collart F et al. Rhinocerebral mucormycosis in haemodialysis patients treated with desferrioxamine: Possible role of recent surgery as an additional risk factor. Nephrol Dial Transplant 1991; 6: 656-658.
182. Rahemtulla A, Durrant ST, Coonar HS, Lee KW, Gordon-Smith EC. Zygomycosis in aplastic anaemia: Response to a combined regimen of amphotericin B and antilymphocyte globulin. Eur J Haematol 1988; 40: 315-317.
183. Blazquez R, Pinedo A, Cosin J, Miralles P, Lacruz C, Bouza E. Nonsurgical cure of isolated cerebral mucormycosis in an intravenous drug user. Eur J Clin Microbiol Infect Dis 1996; 15: 598-599.
184. Dannaoui E, Rijs AJ, Verweij PE. Invasive infections due to Apophysomyces elegans. Mayo Clin Proc 2003; 78: 252-253.
185. Chakrabarti A, Ghosh A, Prasad GS et al. Apophysomyces elegans: An emerging zygomycete in India. J Clin Microbiol 2003; 41: 783-788.
186. Blair JE, Fredrikson LJ, Pockaj BA, Lucaire CS. Locally invasive cutaneous Apophysomyces elegans infection acquired from snapdragon patch test. Mayo Clin Proc 2002; 77: 717-720.
187. Brown SR, Shah IA, Grinstead M. Rhinocerebral mucormycosis caused by Apophysomyces elegans. Am J Rhinol 1998; 12: 289-292.
188. Parfrey NA. Improved diagnosis and prognosis of mucormycosis. A clinicopathologic study of 33 cases. Medicine (Baltimore) 1986; 65: 113-123.
189. Effat KG, Karam M, El-Kabani A. Pott's puffy tumour caused by mucormycosis. J Laryngol Otol 2005; 119: 643-645.
190. Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol 1994;39: 3-22.
191. Ferry AP, Abedi S. Diagnosis and management of rhino-orbitocerebral mucormycosis (phycomycosis). A report of 16 personally observed cases. Ophthalmology 1983; 90: 1096-1104.
192. Bentwich Z, Rosen Z, Ganor S, Herman G. Chronic rhinocerebral mucormycosis (phycomycosis) with occlusion of left internal carotid artery. Isr J Med Sci 1968; 4: 977-981.
193. Jones PG, Gilman RM, Medeiros AA, Dyckman J. Focal intracranial mucormycosis presenting as chronic meningitis. JAMA 1981; 246: 2063-2064.
194. Finn DG, Farmer JC Jr. Chronic mucormycosis. Laryngoscope 1982; 92: 761-766.
195. Bichile LS, Abhyankar SC, Hase NK. Chronic mucormycosis manifesting as hydrocephalus. J Neurol Neurosurg Psychiatry 1985; 48: 1188.
196. Tay AG, Tan CT. Mucormycosis and chronic brain abscess. Med J Aust 1986; 144: 725-726.
197. Hoffman RM. Chronic endobronchial mucormycosis. Chest 1987; 91: 469.
198. Ericsson M, Anniko M, Gustafsson H, Hjalt CA, Stenling R, Tarnvik A. A case of chronic progressive rhinocerebral mucormycosis treated with liposomal amphotericin B and surgery. Clin Infect Dis 1993; 16: 585-586.
199. Harril WC, Stewart MG, Lee AG, Cernoch P. Chronic rhinocerebral mucormycosis. Laryngoscope 1996; 106: 1292-1297.
200. Dhiwakar M, Thakar A, Bahadur S. Improving outcomes in rhinocerebral mucormycosis-early diagnostic pointers and prognostic factors. J Laryngol Otol 2003; 117: 861-865.
201. Lehrer RI, Howard DH. Mucormycosis. Ann Intern Med 1980; 93: 93-108.
202. Bigby TD, Serota ML, Tierney LM Jr, Matthay MA. Clinical spectrum of pulmonary mucormycosis. Chest 1986; 89: 435-439.
203. Lee FY, Mossad SB, Adal KA. Pulmonary mucormycosis: The last 30 years. Arch Intern Med 1999; 159: 1301-1309.
204. Dobrilovic N, Wait MA. Pulmonary mucormycosis. Ann Thorac Surg 2005; 79: 354.
205. Funada H, Matsuda T. Pulmonary mucormycosis in a hematology ward. Intern Med 1996; 35: 540-544.
206. Meyer RD, Armstrong D. Mucormycosis-changing status. CRC Crit Rev Clin Lab Sci 1973; 4: 421-451.
207. Meyer RD, Rosen P, Armstrong D. Phycomycosis complicating leukemia and lymphoma. Ann Intern Med 1972; 77: 871-879.
208. Wolf O, Gil Z, Leider-Trejo L, Khafif A, Biderman P, Fliss DM. Tracheal mucormycosis presented as an intraluminal soft tissue mass. Head Neck 2004; 26: 541-543.
209. Suresh V, Bhansali A, Sridhar C, Dash RJ. Pulmonary mucormycosis presenting with recurrent laryngeal nerve palsy. J Assoc Physicians India 2003; 51: 912-913.
210. Ramirez T, Alvarez-Sala R, Prados C, Nistal M, Casillas M. Bilobectomy and amphotericin B in a case of endobronchial mucormycosis. Thorac Cardiovasc Surg 2000; 48: 245-246.
211. Husari AW, Jensen WA, Kirsch CM et al. Pulmonary mucormycosis presenting as an endobronchial lesion. Chest 1994; 106: 1889-1891.
212. Fermanis GG, Matar KS, Steele R. Endobronchial zygomycosis. Aust N Z J Surg 1991; 61: 391-393.
213. Benbow EW, Bonshek RE, Stoddart RW. Endobronchial zygomycosis. Thorax 1987; 42: 553-554.
214. Donohue JF. Endobronchial mucormycosis. Chest 1983; 83: 585.
215. Donohue JF, Scott RJ, Walker DH, Bromberg PA. Phycomycosis: A cause of bronchial obstruction. South Med J 1980; 73: 734-736.
216. Vaideeswar P. Fatal haemoptysis due to mucormycotic intrapulmonary arterial aneurysm. Int J Cardiol 2002; 83: 273-274.
217. Kitabayashi A, Hirokawa M, Yamaguchi A, Takatsu H, Miura AB. Invasive pulmonary mucormycosis with rupture of the thoracic aorta. Am J Hematol 1998; 58: 326-329.
218. Gupta KL, Khullar DK, Behera D, Radotra BD, Sakhuja V. Pulmonary mucormycosis presenting as fatal massive haemoptysis in a renal transplant recipient. Nephrol Dial Transplant 1998; 13: 3258-3260.
219. Zapatero J, Flandes J, Ruiz-Zafra J et al. Bronchovascular mucormycosis: an urgent surgical problem. Eur J Cardiothorac Surg 1995; 9: 286-288.
220. Pagano L, Ricci P, Nosari A et al. Fatal haemoptysis in pulmonary filamentous mycosis: An underevaluated cause of death in patients with acute leukaemia in haematological complete remission. A retrospective study and review of the literature. Gimema Infection Program (Gruppo Italiano Malattie Ematologiche dell'Adulto). Br J Haematol 1995; 89: 500-505.
221. Dykhuizen RS, Kerr KN, Soutar RL. Fatal haemoptysis in filamentous mycosis. Br J Haematol 1995; 91: 254-255.
222. Harada M, Manabe T, Yamashita K, Okamoto N. Pulmonary mucormycosis with fatal massive hemoptysis. Acta Pathol Jpn 1992; 42: 49-55.
223. Yagihashi S, Watanabe K, Nagai K, Okudaira M. Pulmonary mucormycosis presenting as massive fatal hemoptysis in a hemodialytic patient with chronic renal failure. Klin Wochenschr 1991; 69: 224-227.
224. Passamonte PM, Dix JD. Nosocomial pulmonary mucormycosis with fatal massive hemoptysis. Am J Med Sci 1985; 289: 65-67.
225. van Dam AP, Pruijm MT, Harinck BI, Gelinck LB, Kuijper EJ. Pneumonia involving Aspergillus and Rhizopus spp. after a near-drowning incident with subsequent Nocardia cyriacigeorgici and N. farcinica coinfection as a late complication. Eur J Clin Microbiol Infect Dis 2005; 24: 61-64.
226. Kim Y, Lee KS, Jung KJ, Han J, Kim JS, Suh JS. Halo sign on high resolution CT: Findings in spectrum of pulmonary diseases with pathologic correlation. J Comput Assist Tomogr 1999; 23: 622-626.
227. Jamadar DA, Kazerooni EA, Daly BD, White CS, Gross BH. Pulmonary zygomycosis: CT appearance. J Comput Assist Tomogr 1995; 19: 733-738.
228. Thomas PA, Geraldine P. Rhino-orbito-cerebral mucormycosis. Ind J Ophthalmol 2004; 52: 171-172.
229. Dubey A, Patwardhan RV, Sampth S, Santosh V, Kolluri S, Nanda A. Intracranial fungal granuloma: Analysis of 40 patients and review of the literature. Surg Neurol 2005; 63: 254-260.
230. Cuadrado LM. Cerebral mucormycosis associated with intravenous drug use. Clin Infect Dis 1996; 22: 198.
231. Hopkins RJ, Rothman M, Fiore A, Goldblum SE. Cerebral mucormycosis associated with intravenous drug use: Three case reports and review. Clin Infect Dis 1994; 19(6): 1133-7.
232. Gaing AA, Corbalan F, Weinberger J. Phycomycosis (mucormycosis) in differential diagnosis of cerebral mass lesions in intravenous drug users. Mt Sinai J Med 1992; 59: 69-71.
233. Leen CL, Brettle RP. Fungal infections in drug users. J Antimicrob Chemother 1991; 28 (suppl A): 83-96.
234. Stave GM, Heimberger T, Kerkering TM. Zygomycosis of the basal ganglia in intravenous drug users. Am J Med 1989; 86: 115-117.
235. Wetli CV, Weiss SD, Cleary TJ, Gyori E. Fungal cerebritis from intravenous drug abuse. J Forens Sci 1984; 29: 260-268.
236. Mackenzie DW, Soothill JF, Millar JH. Meningitis caused by Absidia corymbifera. J Infect 1988; 17: 241-248.
237. Peacock JE Jr, McGinnis MR, Cohen MS. Persistent neutrophilic meningitis. Report of four cases and review of the literature. Medicine (Baltimore) 1984; 63: 379-395.
238. Peacock JE Jr. Persistent neutrophilic meningitis. Infect Dis Clin North Am 1990; 4: 747-767.
239. Horre R, Jovanic B, Herff S et.al. Wound infection due to Absidia corymbifera and Candida albicans with fatal outcome. Med Mycol 2004; 42: 373-378.
240. Karim M, Ahmed R, Chishty K. Wound zygomycosis: Two cases with unusual manifestations. Int J Infect Dis 2001; 5: 107-111.
241. Abter EI, Lutwick SM, Chapnick EK et al. Mucormycosis of a median sternotomy wound. Cardiovasc Surg 1994; 2: 474-477.
242. Paparello SF, Parry RL, MacGillivray DC, Brock N, Mayers DL. Hospital-acquired wound mucormycosis. Clin Infect Dis 1992; 14: 350-352.
243. Vainrub B, Macareno A, Mandel S, Musher DM. Wound zygomycosis (mucormycosis) in otherwise healthy adults. Am J Med 1988; 84: 546-548.
244. Codish SD, Sheridan ID, Monaco AP. Mycotic wound infections. A new challenge of the surgeon. Arch Surg 1979; 114: 831-835.
245. Tang D, Wang W. Successful cure of an extensive burn injury complicated with mucor wound sepsis. Burns 1998; 24: 72-73.
246. Kraut EJ, Jordan MH, Steiner CR 3rd. Arterial occlusion and progressive gangrene caused by mucormycosis in a patient with burns. J Burn Care Rehabil 1993; 14: 552-556.
247. Cooter RD, Lim IS, Ellis DH, Leitch IO. Burn wound zygomycosis caused by Apophysomyces elegans. J Clin Microbiol 1990; 28: 2151-2153.
248. Goldschmied-Reouven A, Shvoron A, Topaz M, Block C. Saksenaea vasiformis infection in a burn wound. J Med Vet Mycol 1989; 27: 427-429.
249. Chuntrasakul C, Chantarakul N. Mucormycosis in severely burned patients. Report of two cases with extensive destructive lesions. J Med Assoc Thai 1983; 66: 132-138.
250. Rabin ER, Lundberg GD, Mitchell ET. Mucormycosis in severely burned patients. Report of two cases with extensive destruction of the face and nasal cavity. N Engl J Med 1961; 264: 1286-1289.
251. Kapadia S, Polenakovik H. Cutaneous zygomycosis following attempted radial artery cannulation. Skin Med 2004; 3: 336-338.
252. Rubin AI, Grossman ME. Bull's-eye cutaneous infarct of zygomycosis: A bedside diagnosis confirmed by touch preparation. J Am Acad Dermatol 2004; 51: 996-1001.
253. Everett ED, Pearson S, Rogers W. Rhizopus surgical wound infection with elasticized adhesive tape dressings. Arch Surg 1979; 114: 738-739.
254. Jain JK, Markowitz A, Khilanani PV, Lauter CB. Localized mucormycosis following intramuscular corticosteroid. Case report and review of the literature. Am J Med Sci 1978; 275: 209-216.
255. Geller JD, Peters MS, Su WP. Cutaneous mucormycosis resembling superficial granulomatous pyoderma in an immunocompetent host. J Am Acad Dermatol 1993; 29: 462-465.
256. Kumar A, Khilnani GC, Aggarwal S, Kumar S, Banerjee U, Xess I. Primary cutaneous mucormycosis in an immunocompetent host: Report of a case. Surg Today 2003; 33: 319-322.
257. Miyamoto H, Hayashi H, Nakajima H. Cutaneous mucormycosis in a patient with acute lymphocytic leukemia. J Dermatol 2005; 32: 273-277.
258. Virk SS, Singh RP, Arora AS, Grewal JS, Puri H. Gastric zygomycosis-an unusual cause of massive upper gastrointestinal bleed. Ind J Gastroenterol 2004; 23: 146-147.
259. Maravi-Poma E, Rodriguez-Tudela JL, de Jalon JG et al. Outbreak of gastric mucormycosis associated with the use of wooden tongue depressors in critically ill patients. Intens Care Med 2004; 30: 724-728.
260. Shahapure AG, Patankar RV, Bhatkhande R. Gastric mucormycosis. Ind J Gastroenterol 2002; 21: 231-232.
261. Paulo De Oliveira JE, Milech A. A fatal case of gastric mucormycosis and diabetic ketoacidosis. Endocr Pract 2002; 8: 44-46.
262. Park YS, Lee JD, Kim TH et al. Gastric mucormycosis. Gastrointest Endosc 2002; 56: 904-905.
263. Pickeral JJ 3rd, Silverman JF, Sturgis CD. Gastric zygomycosis diagnosed by brushing cytology. Diagn Cytopathol 2000; 23: 51-54.
264. Al-Rikabi AC, Al-Dohayan AD, Al-Boukai AA. Invasive mucormycosis in benign gastric ulcer. Saudi Med J 2000; 21: 287-290.
265. Cherney CL, Chutuape A, Fikrig MK. Fatal invasive gastric mucormycosis occurring with emphysematous gastritis: Case report and literature review. Am J Gastroenterol 1999; 94: 252-256.
266. Barroso F, Forcelledo JL, Mayorga M, Pena F, Marques FF, de la Pena J. A fatal case of gastric mucormyosis in a heart transplant recipient. Endoscopy 1999; 31: S2.
267. Sheu BS, Lee PC, Yang HB. A giant gastric ulcer caused by mucormycosis infection in a patient with renal transplantation. Endoscopy 1998; 30: S60-S61.
268. Alexander P, Alladi A, Correa M, D'Cruz AJ. Neonatal colonic mucormycosis-a tropical perspective. J Trop Pediatr 2005; 51: 54-59.
269. Gulati S, Barthakur G, Banerjee CK, Singhi S. Zygomycosis of colon. Ind Pediatr 1991; 28: 940-943.
270. Agha FP, Lee HH, Boland CR, Bradley SF. Mucormycoma of the colon: Early diagnosis and successful management. AJR Am J Roentgenol 1985; 145: 739-741.
271. De Feo E. Mucormycosis of the colon. Am J Roentgenol Radium Ther Nucl Med 1961; 86: 86-90.
272. Sellappan B, Bakhshi S, Safaya R, Gupta AK, Arya LS. Invasive colonic mucormycosis in early induction therapy of childhood acute lymphoblastic leukemia. Ind J Pediatr 2005; 72: 77-79.
273. Diven SC, Angel CA, Hawkins HK, Rowen JL, Shattuck KE. Intestinal zygomycosis due to Absidia corymbifera mimicking necrotizing enterocolitis in a preterm neonate. J Perinatol 2004; 24: 794-796.
274. Echo A, Hovsepian RV, Shen GK. Localized cecal zygomycosis following renal transplantation. Transpl Infect Dis 2005; 7: 68-70.
275. Siu KL, Lee WH. A rare cause of intestinal perforation in an extreme low birth weight infant-gastrointestinal mucormycosis: A case report. J Perinatol 2004; 24: 319-321.
276. Manchikalapati P, Canon CL, Jhala N, Eloubeidi MA. Gastrointestinal zygomycosis complicating heart and lung transplantation in a patient with Eisenmenger's syndrome. Dig Dis Sci 2005; 50: 1181-1183.
277. Mekeel KL, Hemming AW, Reed AI et al. Hepatic mucormycosis in a renal transplant recipient. Transplantation 2005; 79: 1636.
278. Mehta NN, Romanelli J, Sutton MG. Native aortic valve vegetative endocarditis with Cunninghamella. Eur J Echocardiogr 2004; 5: 156-158.
279. Erdos MS, Butt K, Weinstein L. Mucormycotic endocarditis of the pulmonary valve. JAMA 1972; 222: 951-953.
280. Buchbinder NA, Roberts WC. Active infective endocarditis confined to mural endocardium. A study of six necropsy patients. Arch Pathol 1972; 93: 435-440.
281. Sanchez-Recalde A, Merino JL, Dominguez F, Mate I, Larrea JL, Sobrino JA. Successful treatment of prosthetic aortic valve mucormycosis. Chest 1999; 116: 1818-1820.
282. Virmani R, Connor DH, McAllister HA. Cardiac mucormycosis. A report of five patients and review of 14 previously reported cases. Am J Clin Pathol 1982; 78: 42-47.
283. Mishra B, Mandal A, Kumar N. Mycotic prosthetic-valve endocarditis. J Hosp Infect 1992; 20: 122-125.
284. Welk B, House AA, Ralph E, Tweedy E, Luke PP. Successful treatment of primary bilateral renal mucormycosis with bilateral nephrectomy. Urology 2004; 64: 590.
285. Singh SK, Wadhwa P, Sakhuja V. Isolated bilateral renal mucormycosis. Urology 2004; 63: 979-980.
286. Jianhong L, Xianliang H, Xuewu J. Isolated renal mucormycosis in children. J Urol 2004; 171: 387-388.
287. Lin CY, Lee SC, Lin CC, Chan SC, Lee CT. Isolated fatal renal mucormycosis in a patient with chronic obstructive pulmonary disease and tuberculosis. Int J Clin Pract 2003; 57: 916-918.
288. Chkhotua A, Yussim A, Tovar A et.al. Mucormycosis of the renal allograft: Case report and review of the literature. Transpl Int 2001; 14: 438-441.
289. Chan LL, Singh S, Jones D, Diaz EM Jr, Ginsberg LE. Imaging of mucormycosis skull base osteomyelitis. AJNR Am J Neuroradiol 2000; 21: 828-831.
290. Stevanovic MV, Mirzayan R, Holtom PD, Schnall SB. Mucormycosis osteomyelitis in the hand. Orthopedics 1999; 22: 449-450.
291. Shaw CJ, Thomason AJ, Spencer JD. Fungal osteomyelitis of the foot. A report of an unusual case. J Bone Joint Surg Br 1994; 76: 137-139.
292. Chaudhuri R, McKeown B, Harrington D, Hay RJ, Bingham JB, Spencer JD. Mucormycosis osteomyelitis causing avascular necrosis of the cuboid bone: MR imaging findings. AJR Am J Roentgenol 1992; 159: 1035-1037.
293. Meis JF, Kullberg BJ, Pruszczynski M, Veth RP. Severe osteomyelitis due to the zygomycete Apophysomyces elegans. J Clin Microbiol 1994; 32: 3078-3081.
294. Pierce PF, Wood MB, Roberts GD, Fitzgerald RH Jr, Robertson C, Edson RS. Saksenaea vasiformis osteomyelitis. J Clin Microbiol 1987; 25: 933-935.
295. Echols RM, Selinger DS, Hallowell C, Goodwin JS, Duncan MH, Cushing AH. Rhizopus osteomyelitis. A case report and review. Am J Med 1979; 66: 141-145.
296. Buruma OJ, Craane H, Kunst MW. Vertebral osteomyelitis and epidural abscess due to mucormycosis, a case report. Clin Neurol Neurosurg 1979; 81: 39-44.
297. Mostaza JM, Barbado FJ, Fernandez-Martin J, Pena-Yanez J, Vazquez-Rodriguez JJ. Cutaneoarticular mucormycosis due to Cunninghamella bertholletiae in a patient with AIDS. Rev Infect Dis 1989; 11: 316-318.
298. Nannini EC, Paphitou NI, Ostrosky-Zeichner L. Peritonitis due to Aspergillus and zygomycetes in patients undergoing peritoneal dialysis: report of 2 cases and review of the literature. Diagn Microbiol Infect Dis 2003; 46: 49-54.
299. Fergie JE, Fitzwater DS, Einstein P, Leggiadro RJ. Mucor peritonitis associated with acute peritoneal dialysis. Pediatr Infect Dis J 1992; 11: 498-500.
300. Polo JR, Luno J, Menarguez C, Gallego E, Robles R, Hernandez P. Peritoneal mucormycosis in a patient receiving continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1989; 13: 237-239.
301. Branton MH, Johnson SC, Brooke JD, Hasbargen JA. Peritonitis due to Rhizopus in a patient undergoing continuous ambulatory peritoneal dialysis. Rev Infect Dis 1991; 13: 19-21.
302. Nakamura M, Weil WB Jr, Kaufman DB. Fatal fungal peritonitis in an adolescent on continuous ambulatory peritoneal dialysis: Association with deferoxamine. Pediatr Nephrol 1989; 3: 80-82.
303. Sammassimo S, Mazzotta S, Tozzi M et al. Disseminated mucormycosis in a patient with acute myeloblastic leukemia misdiagnosed as infection by Enterococcus faecium. J Clin Microbiol 2004; 42: 487-489.
304. Blin N, Morineau N, Gaillard F et al. Disseminated mucormycosis associated with invasive pulmonary aspergillosis in a patient treated for post-transplant high-grade non-Hodgkin's lymphoma. Leuk Lymphoma 2004; 45: 2161-2163.
305. Basti A, Taylor S, Tschopp M, Sztajzel J. Fatal fulminant myocarditis caused by disseminated mucormycosis. Heart 2004; 90: E60.
306. Doucette KE, Galbraith PA, Bow EJ, Binda BJ, Rendina A, Embil JM. Disseminated zygomycosis: A rare cause of infection in patients with hematologic malignancies. J Trauma 2003; 55: 568-570.
307. Dannaoui E, Meis JF, Loebenberg D, Verweij PE. Activity of posaconazole in treatment of experimental disseminated zygomycosis. Antimicrob Agents Chemother 2003; 47: 3647-3650.
308. Yamauchi T, Misaki H, Arai H, Iwasaki H, Naiki H, Ueda T. An autopsy case of disseminated mucormycosis in a neutropenic patient receiving chemotherapy for the underlying solid malignancy. J Infect Chemother 2002; 8: 103-105.
309. Lee DG, Choi JH, Choi SM et al. Two cases of disseminated mucormycosis in patients following allogeneic bone marrow transplantation. J Korean Med Sci 2002; 17: 403-406.
310. Rickerts V, Loeffler J, Bohme A, Einsele H, Just-Nubling G. Diagnosis of disseminated zygomycosis using a polymerase chain reaction assay. Eur J Clin Microbiol Infect Dis 2001; 20: 744-745.
311. Liu MF, Chen FF, Hsiue TR, Liu CC. Disseminated zygomycosis simulating cerebrovascular disease and pulmonary alveolar haemorrhage in a patient with systemic lupus erythematosus. Clin Rheumatol 2000; 19: 311-314.
312. Eucker J, Sezer O, Lehmann R et al. Disseminated mucormycosis caused by Absidia corymbifera leading to cerebral vasculitis. Infection 2000; 28: 246-250.
313. Anstead GM, Sutton DA, Thompson EH, Weitzman I, Otto RA, Ahuja SK. Disseminated zygomycosis due to Rhizopus schipperae after heatstroke. J Clin Microbiol 1999; 37: 2656-2662.
314. Cuvelier I, Vogelaers D, Peleman R et al. Two cases of disseminated mucormycosis in patients with hematological malignancies and literature review. Eur J Clin Microbiol Infect Dis 1998; 17: 859-863.
315. Maury S, Leblanc T, Feuilhade M, Molina JM, Schaison G. Successful treatment of disseminated mucormycosis with liposomal amphotericin B and surgery in a child with leukemia. Clin Infect Dis 1998; 26: 200-202.
316. Ibanez R, Serrano-Heranz R, Sanchez-Zaballos I, Carbonero P, Lopez G. Disseminated mucormycosis due to Absidia corymbifera in a patient with inflammatory bowel disease. Clin Microbiol Infect 1997; 3: 268-270.
317. Gonzalez CE, Couriel DR, Walsh TJ. Disseminated zygomycosis in a neutropenic patient: Successful treatment with amphotericin B lipid complex and granulocyte colony-stimulating factor. Clin Infect Dis 1997; 24: 192-196.
318. von Pohle WR. Disseminated mucormycosis presenting with lower extremity weakness. Eur Respir J 1996; 9: 1751-1753.
319. Torres L, Fortuno B, Santacruz C et al. Zigomicosis diseminada por Absidia corymbifera en dos pacientes con leucemia. Enferm Infecc Microbiol Clin 1996; 14: 608-610.
320. Celgow L, Cohn RJ, Sacks AJ. Disseminated mucormycosis: Report of a successfully treated immunosuppressed child with clinical, radiographic and pathological findings. Pediatr Radiol 1996; 26: 131-133.
321. Verma GR, Lobo DR, Walker R, Bose SM, Gupta KL. Disseminated mucormycosis in healthy adults. J Postgrad Med 1995; 41: 40-42.
322. Eucker J, Sezer O, Graf B, Possinger K. Mucormycoses. Mycoses 2001; 44: 253-260.
323. Meyer RD, Kaplan MH, Ong M, Armstrong D. Cutaneous lesions in disseminated mucormycosis. JAMA 1973; 225: 737-738.
324. Pagano L, Offidani M, Fianchi L et al. Mucormycosis in hematologic patients. Haematologica 2004; 89: 207-214.
325. Mori T, Egashira M, Kawamata N et al. Zygomycosis: Two case reports and review of reported cases in the literature in Japan. Nippon Ishinkin Gakkai Zasshi 2003; 44: 163-179.
326. Reid VJ, Solnik DL, Daskalakis T, Sheka KP. Management of bronchovascular mucormycosis in a diabetic: A surgical success. Ann Thorac Surg 2004; 78: 1449-1451.
327. Pavie J, Lafaurie M, Lacroix C et al. Successful treatment of pulmonary mucormycosis in an allogenic bone-marrow transplant recipient with combined medical and surgical therapy. Scand J Infect Dis 2004; 36: 767-769.
328. Asai K, Suzuki K, Takahashi T, Ito Y, Kazui T, Kita Y. Pulmonary resection with chest wall removal and reconstruction for invasive pulmonary mucormycosis during antileukemia chemotherapy. Jpn J Thorac Cardiovasc Surg 2003; 51: 163-166.
329. Walsh TJ, Hiemenz JW, Seibel NL et al. Amphotericin B lipid complex for invasive fungal infections: Analysis of safety and efficacy in 556 cases. Clin Infect Dis 1998; 26: 1383-1396.
330. Weng DE, Wilson WH, Little R, Walsh TJ. Successful medical management of isolated renal zygomycosis: Case report and review. Clin Infect Dis 1998; 26: 601-605.
331. Spellberg B, Fu Y, Edwards JE Jr, Ibrahim AS. Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice. Antimicrob Agents Chemother 2005; 49: 830-832.
332. Perfect JR. Treatment of non- Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex. Clin Infect Dis 2005; 40(suppl 6): S401-S408.
333. Ibrahim AS, Avanessian V, Spellberg B, Edwards JE Jr. Liposomal amphotericin B, and not amphotericin B deoxycholate, improves survival of diabetic mice infected with Rhizopus oryzae. Antimicrob Agents Chemother 2003; 47: 3343-3344.
334. Sun QN, Fothergill AW, McCarthy DI, Rinaldi MG, Graybill JR. In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes. Antimicrob Agents Chemother 2002; 46: 1581-1582.
335. Eisen DP, Robson J. Complete resolution of pulmonary Rhizopus oryzae infection with itraconazole treatment: More evidence of the utility of azoles for zygomycosis. Mycoses 2004; 47: 159-162.
336. Dannaoui E, Meletiadis J, Mouton JW, Meis JF, Verweij PE. In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 2003; 51: 45-52.
337. Van Cutsem J, Van Gerven F, Fransen J, Janssen PA. Treatment of experimental zygomycosis in guinea pigs with azoles and with amphotericin B. Chemotherapy 1989; 35: 267-272.
338. Pfaller MA, Messer SA, Hollis RJ, Jones RN. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: Report from SENTRY Antimicrobial Surveillance Program, 2000. Antimicrob Agents Chemother 2002; 46: 1032-1037.
339. Gil-Lamaignere C, Hess R, Salvenmoser S, Heyn K, Kappe R, Muller FM. Effect of media composition and in vitro activity of posaconazole, caspofungin and voriconazole against zygomycetes. J Antimicrob Chemother 2005; 55: 1016-1019.
340. Keating GM. Posaconazole. Drugs 2005; 65: 1553-1567; discussion 1568-1569.
341. Dupont B. Pulmonary mucormycosis (zygomycosis) in a lung transplant recipient: Recovery after posaconazole therapy. Transplantation 2005; 80: 544-545.
342. Sun QN, Najvar LK, Bocanegra R, Loebenberg D, Graybill JR. In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model. Antimicrob Agents Chemother 2002; 46: 2310-2312.
343. Gilman AL, Serrano A, Skelley J, Zwick D. Successful treatment of pulmonary zygomycosis with posaconazole in a recipient of a haploidentical donor stem cell transplant. Pediatr Blood Cancer 2006; 47: 959-963.
344. Ibrahim AS, Bowman JC, Avanessian V et.al. Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis. Antimicrob Agents Chemother 2005; 49: 721-727.
345. Chassaing N, Valton L, Kany M et.al. Rhino-cerebral fungal infection successfully treated with supplementary hyperbaric oxygen therapy. Rev Neurol (Paris) 2003; 159: 1178-1180.
346. Couch L, Theilen F, Mader JT. Rhinocerebral mucormycosis with cerebral extension successfully treated with adjunctive hyperbaric oxygen therapy. Arch Otolaryngol Head Neck Surg 1988; 114: 791-794.
347. Garcia-Covarrubias L, Barratt DM, Bartlett R, Van Meter K. Treatment of mucormycosis with adjunctive hyperbaric oxygen: Five cases treated at the same institution and review of the literature. Rev Invest Clin 2004; 56: 51-55.
348. John BV, Chamilos G, Kontoyiannis DP. Hyperbaric oxygen as an adjunctive treatment for zygomycosis. Clin Microbiol Infect 2005; 11: 515-517.
349. Abzug MJ, Walsh TJ. Interferon-gamma and colony-stimulating factors as adjuvant therapy for refractory fungal infections in children. Pediatr Infect Dis J 2004; 23: 769-773.
350. Gil-Lamaignere C, Simitsopoulou M, Roilides E, Maloukou A, Winn RM, Walsh TJ. Interferon-gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important Zygomycetes. J Infect Dis 2005; 191: 1180-1187.
351. Bullock JD, Jampol LM, Fezza AJ. Two cases of orbital phycomycosis with recovery. Am J Ophthalmol 1974; 78: 811-815.